• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖调节三阴性乳腺癌的肠道微生物组。

Obesity Modulates the Gut Microbiome in Triple-Negative Breast Cancer.

机构信息

School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

Department of Microbiology, Immunology and Genetics, University of North Texas Health Sciences Center, Fort Worth, TX 76107, USA.

出版信息

Nutrients. 2021 Oct 19;13(10):3656. doi: 10.3390/nu13103656.

DOI:10.3390/nu13103656
PMID:34684657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8539565/
Abstract

Triple-negative breast cancer (TNBC) is an aggressive, molecularly heterogeneous subtype of breast cancer. Obesity is associated with increased incidence and worse prognosis in TNBC through various potential mechanisms. Recent evidence suggests that the gut microbiome plays a central role in the progression of cancer, and that imbalances or dysbiosis in the population of commensal microbiota can lead to inflammation and contribute to tumor progression. Obesity is characterized by low-grade inflammation, and gut dysbiosis is associated with obesity, chronic inflammation, and failure of cancer immunotherapy. However, the debate on what constitutes a "healthy" gut microbiome is ongoing, and the connection among the gut microbiome, obesity, and TNBC has not yet been addressed. This study aims to characterize the role of obesity in modulating the gut microbiome in a syngeneic mouse model of TNBC. 16S rRNA sequencing and metagenomic analyses were performed to analyze and annotate genus and taxonomic profiles. Our results suggest that obesity decreases alpha diversity in the gut microbiome. Metagenomic analysis revealed that obesity was the only significant factor explaining the similarity of the bacterial communities according to their taxonomic profiles. In contrast to the analysis of taxonomic profiles, the analysis of variation of functional profiles suggested that obesity status, tumor presence, and the obesity-tumor interaction were significant in explaining the variation of profiles, with obesity having the strongest correlation. The presence of tumor modified the profiles to a greater extent in obese than in lean animals. Further research is warranted to understand the impact of the gut microbiome on TNBC progression and immunotherapy.

摘要

三阴性乳腺癌(TNBC)是一种侵袭性的、分子异质性的乳腺癌亚型。肥胖通过多种潜在机制与 TNBC 的发病率增加和预后恶化相关。最近的证据表明,肠道微生物组在癌症的进展中起着核心作用,共生微生物群落的失衡或失调会导致炎症,并促进肿瘤进展。肥胖的特点是低度炎症,肠道菌群失调与肥胖、慢性炎症和癌症免疫治疗失败有关。然而,关于什么构成“健康”的肠道微生物组的争论仍在继续,肠道微生物组、肥胖和 TNBC 之间的联系尚未得到解决。本研究旨在表征肥胖在调节 TNBC 同源小鼠模型中肠道微生物组中的作用。进行了 16S rRNA 测序和宏基因组分析,以分析和注释属和分类群谱。我们的结果表明,肥胖会降低肠道微生物组的 alpha 多样性。宏基因组分析表明,肥胖是唯一能够根据细菌分类群谱解释细菌群落相似性的显著因素。与分类群谱分析相比,功能谱变异分析表明,肥胖状况、肿瘤存在以及肥胖-肿瘤相互作用在解释谱的变异方面是显著的,其中肥胖的相关性最强。肿瘤的存在使肥胖动物的肠道微生物组发生了更大的改变。需要进一步研究以了解肠道微生物组对 TNBC 进展和免疫治疗的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/069686ec0906/nutrients-13-03656-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/73859b3e1d9b/nutrients-13-03656-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/87ea72478a68/nutrients-13-03656-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/0d2a4cb8b99e/nutrients-13-03656-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/1e17492d713f/nutrients-13-03656-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/2c4730405057/nutrients-13-03656-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/069686ec0906/nutrients-13-03656-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/73859b3e1d9b/nutrients-13-03656-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/87ea72478a68/nutrients-13-03656-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/0d2a4cb8b99e/nutrients-13-03656-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/1e17492d713f/nutrients-13-03656-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/2c4730405057/nutrients-13-03656-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268f/8539565/069686ec0906/nutrients-13-03656-g006.jpg

相似文献

1
Obesity Modulates the Gut Microbiome in Triple-Negative Breast Cancer.肥胖调节三阴性乳腺癌的肠道微生物组。
Nutrients. 2021 Oct 19;13(10):3656. doi: 10.3390/nu13103656.
2
Tributyltin exposure induces gut microbiome dysbiosis with increased body weight gain and dyslipidemia in mice.三丁基锡暴露导致肠道微生物组失调,增加小鼠体重增加和血脂异常。
Environ Toxicol Pharmacol. 2018 Jun;60:202-208. doi: 10.1016/j.etap.2018.04.020. Epub 2018 May 3.
3
Association of gut microbiota composition and function with a senescence-accelerated mouse model of Alzheimer's Disease using 16S rRNA gene and metagenomic sequencing analysis.利用16S rRNA基因和宏基因组测序分析,研究肠道微生物群组成和功能与阿尔茨海默病衰老加速小鼠模型的关联。
Aging (Albany NY). 2018 Dec 18;10(12):4054-4065. doi: 10.18632/aging.101693.
4
Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.肠道微生物群介导膳食辣椒素对高脂饮食诱导的慢性低度炎症和相关肥胖的保护作用。
mBio. 2017 May 23;8(3):e00470-17. doi: 10.1128/mBio.00470-17.
5
A metagenomic study of the gut microbiome in Behcet's disease.贝赫切特病肠道微生物组的宏基因组学研究。
Microbiome. 2018 Aug 4;6(1):135. doi: 10.1186/s40168-018-0520-6.
6
Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses.基于宏基因组和宏转录组分析揭示的小鼠肠道微生物组中细菌物种的功能动态。
PLoS One. 2020 Jan 24;15(1):e0227886. doi: 10.1371/journal.pone.0227886. eCollection 2020.
7
Comparative analysis of gut microbiota associated with body mass index in a large Korean cohort.一项大型韩国队列中与体重指数相关的肠道微生物群的比较分析。
BMC Microbiol. 2017 Jul 4;17(1):151. doi: 10.1186/s12866-017-1052-0.
8
Microbiome Analysis Reveals Diversity and Function of Associated with the Eastern Oyster, .微生物组分析揭示了与东方牡蛎相关的微生物的多样性和功能。
mSphere. 2021 May 12;6(3):e00227-21. doi: 10.1128/mSphere.00227-21.
9
Different gut microbiome composition in obese Guizhou minipigs between female and castrated male.肥胖贵州小型猪雌雄个体间肠道微生物组成的差异。
Folia Microbiol (Praha). 2019 Nov;64(6):889-898. doi: 10.1007/s12223-019-00704-4. Epub 2019 Apr 22.
10
Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.与孤立性肌张力障碍相关的肠道微生物组和血清代谢组变化。
mSphere. 2021 Aug 25;6(4):e0028321. doi: 10.1128/mSphere.00283-21. Epub 2021 Aug 4.

引用本文的文献

1
Microbial Signatures in Breast Cancer: Exploring New Potentials Across Body Niches.乳腺癌中的微生物特征:探索全身生态位的新潜力
Int J Mol Sci. 2025 Sep 5;26(17):8654. doi: 10.3390/ijms26178654.
2
Immunometabolic Interactions in Obesity: Implications for Therapeutic Strategies.肥胖中的免疫代谢相互作用:对治疗策略的启示。
Biomedicines. 2025 Jun 10;13(6):1429. doi: 10.3390/biomedicines13061429.
3
Unraveling molecular interconnections and identifying potential therapeutic targets of significance in obesity-cancer link.揭示肥胖与癌症关联中的分子相互联系并确定具有重要意义的潜在治疗靶点。

本文引用的文献

1
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects.免疫检查点抑制剂在三阴性乳腺癌治疗中的应用:前景广阔。
Front Oncol. 2021 Feb 25;10:600573. doi: 10.3389/fonc.2020.600573. eCollection 2020.
2
Alterations of Gut Microbiota by Overnutrition Impact Gluconeogenic Gene Expression and Insulin Signaling.过度营养引起的肠道微生物组改变影响糖异生基因表达和胰岛素信号。
Int J Mol Sci. 2021 Feb 20;22(4):2121. doi: 10.3390/ijms22042121.
3
Immunotherapy in Triple-Negative Breast Cancer.三阴性乳腺癌的免疫治疗。
J Natl Cancer Cent. 2024 Nov 28;5(1):8-27. doi: 10.1016/j.jncc.2024.11.001. eCollection 2025 Feb.
4
Obesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy.肥胖、菌群失调和炎症:调节免疫疗法疗效的相互作用。
Front Immunol. 2024 Aug 26;15:1444589. doi: 10.3389/fimmu.2024.1444589. eCollection 2024.
5
Bibliometric analysis of global research trends between gut microbiota and breast cancer: from 2013 to 2023.2013年至2023年全球肠道微生物群与乳腺癌研究趋势的文献计量分析
Front Microbiol. 2024 Jul 31;15:1393422. doi: 10.3389/fmicb.2024.1393422. eCollection 2024.
6
Nutrition and Dietary Intervention in Cancer: Gaps, Challenges, and Future Perspectives.癌症的营养与膳食干预:差距、挑战与未来展望。
Cancer Treat Res. 2024;191:281-307. doi: 10.1007/978-3-031-55622-7_11.
7
Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy.特定微生物群模式及其与乳腺癌的关联:肠道微生物群作为一种潜在的生物标志物和治疗策略。
Clin Transl Oncol. 2025 Jan;27(1):15-41. doi: 10.1007/s12094-024-03554-w. Epub 2024 Jun 18.
8
le of Gut icrobe Composition in Psychosocial Symptom Response to xercise Training in Breast Cancer Survivors (ROME) study: protocol for a randomised controlled trial.乳腺癌幸存者心理社会症状对运动训练反应中肠道微生物组成的作用(ROME)研究:一项随机对照试验的方案。
BMJ Open. 2024 May 3;14(5):e081660. doi: 10.1136/bmjopen-2023-081660.
9
Diet Modulates the Gut Microbiome, Metabolism, and Mammary Gland Inflammation to Influence Breast Cancer Risk.饮食可调节肠道微生物群、代谢和乳腺炎症,从而影响乳腺癌风险。
Cancer Prev Res (Phila). 2024 Sep 4;17(9):415-428. doi: 10.1158/1940-6207.CAPR-24-0055.
10
Polydatin ameliorates low-density lipoprotein cholesterol and lipid metabolism by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in triple-negative breast cancer with hyperlipidemia.虎杖苷通过下调高脂血症三阴性乳腺癌中前蛋白转化酶枯草溶菌素/kexin 9型(PCSK9)来改善低密度脂蛋白胆固醇和脂质代谢。
Am J Cancer Res. 2024 Jan 15;14(1):52-72. doi: 10.62347/BRNK8140. eCollection 2024.
Cancer J. 2021;27(1):59-66. doi: 10.1097/PPO.0000000000000497.
4
Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.种族差异与三阴性乳腺癌:生物学和非生物学因素作用的综述。
Front Public Health. 2020 Dec 22;8:576964. doi: 10.3389/fpubh.2020.576964. eCollection 2020.
5
Triple‑negative breast cancer therapy: Current and future perspectives (Review).三阴性乳腺癌治疗:现状和未来展望(综述)。
Int J Oncol. 2020 Dec;57(6):1245-1261. doi: 10.3892/ijo.2020.5135. Epub 2020 Oct 16.
6
Mucus barrier, mucins and gut microbiota: the expected slimy partners?黏液屏障、黏蛋白和肠道微生物群:理想的黏糊搭档?
Gut. 2020 Dec;69(12):2232-2243. doi: 10.1136/gutjnl-2020-322260. Epub 2020 Sep 11.
7
The Genus : Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health.属:具有潜在炎症、癌症和精神健康影响的肠道细菌。
Front Immunol. 2020 Jun 9;11:906. doi: 10.3389/fimmu.2020.00906. eCollection 2020.
8
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis.他汀类药物治疗与肠道微生物群落失调的患病率降低有关。
Nature. 2020 May;581(7808):310-315. doi: 10.1038/s41586-020-2269-x. Epub 2020 May 6.
9
Interaction between microbiota and immunity in health and disease.肠道菌群与免疫在健康与疾病中的相互作用。
Cell Res. 2020 Jun;30(6):492-506. doi: 10.1038/s41422-020-0332-7. Epub 2020 May 20.
10
Microbiome and Breast Cancer: New Role for an Ancient Population.微生物群与乳腺癌:古老群体的新作用。
Front Oncol. 2020 Feb 12;10:120. doi: 10.3389/fonc.2020.00120. eCollection 2020.